ESC Premium Access

Effects of upgrade versus de-novo cardiac resynchronization therapy on clinical response and long-term survival: Results form a large multicenter study

Congress Presentation

About the speaker

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)
0 follower

9 more presentations in this session

A novel algorithm increases effective left ventricular pacing during atrial fibrillation in patients undergoing cardiac resynchronization therapy: primary results of the randomized CRTee trial

Speaker: Doctor S. Mittal (Ridgewood, US)


Early AV node ablation versus pharmacological rate control in patients with CRT and AF. Results of SPARE III, a randomized multicenter study.

Speaker: Doctor M. Trucco (Girona, ES)


Cardiac resynchronization therapy defibrillator at the end of battery life; is time to discuss the need to re-implant a device with defibrillator back-up in all patients?

Speaker: Doctor R. Rordorf (Pavia, IT)


Device-related infective endocarditis in cardiac resynchronization therapy recipients - single center registry with over 2500 person-years follow up

Speaker: Mrs E. Jedrzejczyk-Patej (Zabrze, PL)


Impact of multi-point left ventricular pacing on left ventricular ejection fraction: preliminary results from an italian multicenter prospective registry (iron mpp).

Speaker: Doctor L. Santini (Rome, IT)


Access the full session

Clinical results in CRT: patient groups, leads and optimisation

Speakers: Associate Professor M. Vamos, Doctor S. Mittal, Doctor M. Trucco, Doctor R. Rordorf, Mrs E. Jedrzejczyk-Patej...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb